A neutrophil/lymphocyte Ratio as a Significant Predictor for Patients with low-risk and early-stage Extranodal NK-T-cell Lymphoma

Kwong YL (2005) Natural killer-cell malignancies: diagnosis and treatment. Leukemia 19(12):2186–2194. doi:https://doi.org/10.1038/sj.leu.2403955

Article  CAS  PubMed  Google Scholar 

Haverkos BM, Pan Z, Gru AA et al (2016) Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases. Curr Hematol Malig Rep 11(6):514–527. doi:https://doi.org/10.1007/s11899-016-0355-9

Article  PubMed  PubMed Central  Google Scholar 

Fox CP, Civallero M, Ko YH et al (2020) Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project. Lancet Haematol 7(4):e284–e294. doi:https://doi.org/10.1016/S2352-3026(19)30283-2

Article  PubMed  Google Scholar 

Yang QP, Zhang WY, Yu JB et al (2011) Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 6:77 Published 2011 Aug 22. doi:https://doi.org/10.1186/1746-1596-6-77

Article  PubMed  PubMed Central  Google Scholar 

Bi XW, Xia Y, Zhang WW et al (2015) Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma. Ann Hematol 94(9):1525–1533. doi:https://doi.org/10.1007/s00277-015-2395-y

Article  CAS  PubMed  Google Scholar 

Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW (2002) Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54(1):182–190. doi:https://doi.org/10.1016/s0360-3016(02)02916-4

Article  PubMed  Google Scholar 

Hong H, Li Y, Lim ST et al (2020) A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group. Leukemia 34(8):2243–2248. doi:https://doi.org/10.1038/s41375-020-0740-1

Article  PubMed  PubMed Central  Google Scholar 

Tan KM, Chia B, Lim JQ et al (2019) A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study. Sci Rep. ;9(1):14961. Published 2019 Oct 18. doi:https://doi.org/10.1038/s41598-019-51522-0

International Non-Hodgkin’s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329(14):987–994. doi:https://doi.org/10.1056/NEJM199309303291402

Article  Google Scholar 

Lee J, Suh C, Park YH et al (2006) Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 24(4):612–618. doi:https://doi.org/10.1200/JCO.2005.04.1384

Article  PubMed  Google Scholar 

Kim SJ, Yoon DH, Jaccard A et al (2016) A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol 17(3):389–400. doi:https://doi.org/10.1016/S1470-2045(15)00533-1

Article  CAS  PubMed  Google Scholar 

Greten FR, Grivennikov SI (2019) Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity 51(1):27–41. doi:https://doi.org/10.1016/j.immuni.2019.06.025

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA (2013) Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13(11):759–771. doi:https://doi.org/10.1038/nrc3611

Article  CAS  PubMed  Google Scholar 

Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ (2013) The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88(1):218–230. doi:https://doi.org/10.1016/j.critrevonc.2013.03.010

Article  PubMed  Google Scholar 

Templeton AJ, McNamara MG, Šeruga B et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. ;106(6):dju124. Published 2014 May 29. doi:https://doi.org/10.1093/jnci/dju124

Diem S, Schmid S, Krapf M et al (2017) Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer 111:176–181. doi:https://doi.org/10.1016/j.lungcan.2017.07.024

Article  PubMed  Google Scholar 

Chen MF, Chen PT, Kuan FC, Chen WC (2019) The Predictive Value of Pretreatment Neutrophil-To-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 26(1):190–199. doi:https://doi.org/10.1245/s10434-018-6944-1

Article  PubMed  Google Scholar 

Zheng L, Zou K, Yang C, Chen F, Guo T, Xiong B (2017) Inflammation-based indexes and clinicopathologic features are strong predictive values of preoperative circulating tumor cell detection in gastric cancer patients. Clin Transl Oncol 19(9):1125–1132. doi:https://doi.org/10.1007/s12094-017-1649-7

Article  CAS  PubMed  Google Scholar 

Sherry AD, von Eyben R, Newman NB et al (2020) Systemic Inflammation After Radiation Predicts Locoregional Recurrence, Progression, and Mortality in Stage II-III Triple-Negative Breast Cancer. Int J Radiat Oncol Biol Phys 108(1):268–276. doi:https://doi.org/10.1016/j.ijrobp.2019.11.398

Article  PubMed  Google Scholar 

Wang S, Ma Y, Sun L et al Prognostic Significance of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma.Biomed Res Int. 2018;2018:9651254. Published 2018 Dec 12. doi: https://doi.org/10.1155/2018/9651254

Sabattini E, Bacci F, Sagramoso C, Pileri SA (2010) WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102(3):83–87

CAS  PubMed  Google Scholar 

Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the Committee on Hodgkin’s Disease Staging Classification. Cancer Res 31(11):1860–1861

CAS  PubMed  Google Scholar 

Jiang M, Zhang L, Xie L et al (2017) A phase II prospective study of the “Sandwich” protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma. Oncotarget 8(30):50155–50163. doi:https://doi.org/10.18632/oncotarget.16334

Article  PubMed  PubMed Central  Google Scholar 

Jiang M, Zhang H, Jiang Y et al (2012) Phase 2 trial of “sandwich” L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma. Cancer 118(13):3294–3301. doi:https://doi.org/10.1002/cncr.26629

Article  CAS  PubMed  Google Scholar 

Zhang L, Li S, Jia S et al (2016) The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type. Oncotarget 7(36):58396–58404. doi:https://doi.org/10.18632/oncotarget.11135

Article  PubMed  PubMed Central  Google Scholar 

Wei W, Wu P, Li L, Zhang ZH (2017) Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma. Hematology 22(6):320–329. doi:https://doi.org/10.1080/10245332.2016.1264163

Article  CAS  PubMed  Google Scholar 

Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059–3068. doi:https://doi.org/10.1200/JCO.2013.54.8800

Article  PubMed  PubMed Central  Google Scholar 

DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845

Article  CAS  PubMed  Google Scholar 

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. doi:https://doi.org/10.1016/j.cell.2011.02.013

Article  CAS  PubMed  Google Scholar 

Mollinedo F (2019) Neutrophil Degranulation, Plasticity, and Cancer Metastasis. Trends Immunol 40(3):228–242. doi:https://doi.org/10.1016/j.it.2019.01.006

Article  CAS  PubMed  Google Scholar 

Shaul ME, Fridlender ZG (2019) Tumour-associated neutrophils in patients with cancer. Nat Rev Clin Oncol 16(10):601–620. doi:https://doi.org/10.1038/s41571-019-0222-4

Article  PubMed  Google Scholar 

Farkas T, Müller J, Erdelyi DJ, Csoka M, Kovacs GT (2017) Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia. Pathol Oncol Res 23(4):889–897. doi:https://doi.org/10.1007/s12253-017-0192-8

Article  CAS  PubMed  Google Scholar 

Zhou X, Sun X, Zhao W, Fang X, Wang X (2019) Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma. Cancer Manag Res 11:4243–4254 Published 2019 May 7. doi:https://doi.org/10.2147/CMAR.S193397

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu Y, Chen M, Song Y et al (2020) Study of L-Asparaginase, Vincristine, and Dexamethasone Combined With Intensity-modulated Radiation Therapy in Early-Stage Nasal NK/T-Cell Lymphoma. Am J Clin Oncol 43(4):257–262. doi:https://doi.org/10.1097/COC.0000000000000647

Article  CAS  PubMed  Google Scholar 

Kim SJ, Yang DH, Kim JS et al (2014) Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study. Ann Hematol 93(11):1895–1901. doi:https://doi.org/10.1007/s00277-014-2137-6

Article  CAS  PubMed  Google Scholar 

Qi SN, Yang Y, Song YQ et al (2020) First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG [published correction appears in Blood Adv. 2021 Jun 17;5(12):2576]. Blood Adv. ;4(13):3141–3153. doi:https://doi.org/10.1182/bloodadvances.2020001852

Zhao Y, Shi Y, Shen H et al (2020) The prognostic value of platelet-lymphocyte ratio and neutrophil-lymphocyte ratio in the treatment response and survival of patients with peripheral T-cell lymphoma. Leuk Lymphoma 61(3):623–630. doi:https://doi.org/10.1080/10428194.2019.1700244

Article  CAS  PubMed  Google Scholar 

Beltran BE, Castro D, De La Cruz-Vargas JA, Cotrina E, Gallo A, Sotomayor EM, Castillo JJ (2019) The neutrophil-lymphocyte ratio is prognostic in patients with early stage aggressive peripheral T cell lymphoma. Br J Haematol 184:650–653

Article  PubMed 

留言 (0)

沒有登入
gif